The Role of Internal Limiting Membrane as a Biomarker in the Evolution of Myopic Traction Maculopathy

Purpose: To describe the longitudinal structural changes of myopic traction maculopathy (MTM) based on optical coherence tomography (OCT) and to detect biomarkers in the evolution of MTM.Methods: A retrospective study was conducted on patients with MTM as defined by OCT. A minimum follow-up of 6 mon...

Full description

Bibliographic Details
Main Authors: Dong Fang, Jindi Su, Lu Chen, Shaochong Zhang
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-01-01
Series:Frontiers in Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2021.802626/full
_version_ 1818974636195446784
author Dong Fang
Jindi Su
Lu Chen
Shaochong Zhang
author_facet Dong Fang
Jindi Su
Lu Chen
Shaochong Zhang
author_sort Dong Fang
collection DOAJ
description Purpose: To describe the longitudinal structural changes of myopic traction maculopathy (MTM) based on optical coherence tomography (OCT) and to detect biomarkers in the evolution of MTM.Methods: A retrospective study was conducted on patients with MTM as defined by OCT. A minimum follow-up of 6 months was necessary for study inclusion. The effects of comprehensive OCT-based structure on the evolution of MTM, the progression rates, and resolution rates of MTM were evaluated.Results: A total of 120 eyes (120 patients) were included with an average follow-up of 15.4 months. During the follow-up, MTM progressed in 32 eyes (26.67%). The most common pattern of progression observed was the increased extent of retinoschisis in 12 eyes. The multivariate analysis showed that the presence of MTM progression had a significant correlation with internal limiting membrane (ILM) detachment and retinoschisis involved the entire macula at baseline. Five eyes (4.17%) experienced MTM resolution, of which 2 eyes developed disruptions of detached ILM, two eyes developed disruptions of epiretinal membrane, and one eye developed partial posterior vitreous detachment. Eyes with foveal detachment showed the highest progression rate (41.67%) and highest resolution rate (16.67%) compared to the eyes with other foveal complications.Conclusion: ILM detachment is a risk factor for MTM progression and MTM resolution can occur after ILM disruption. These suggest that ILM may play an important role as a biomarker in the evolution of MTM.
first_indexed 2024-12-20T15:43:12Z
format Article
id doaj.art-4f8bb82138d54a7fbc5d575a212ca19a
institution Directory Open Access Journal
issn 2296-858X
language English
last_indexed 2024-12-20T15:43:12Z
publishDate 2022-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Medicine
spelling doaj.art-4f8bb82138d54a7fbc5d575a212ca19a2022-12-21T19:35:07ZengFrontiers Media S.A.Frontiers in Medicine2296-858X2022-01-01810.3389/fmed.2021.802626802626The Role of Internal Limiting Membrane as a Biomarker in the Evolution of Myopic Traction MaculopathyDong Fang0Jindi Su1Lu Chen2Shaochong Zhang3Shenzhen Eye Hospital, Jinan University, Shenzhen Key Laboratory of Ophthalmology, Shenzhen, ChinaAffiliated Shenzhen Maternity and Child Healthcare Hospital, Southern Medical University, Shenzhen, ChinaShenzhen Eye Hospital, Jinan University, Shenzhen Key Laboratory of Ophthalmology, Shenzhen, ChinaShenzhen Eye Hospital, Jinan University, Shenzhen Key Laboratory of Ophthalmology, Shenzhen, ChinaPurpose: To describe the longitudinal structural changes of myopic traction maculopathy (MTM) based on optical coherence tomography (OCT) and to detect biomarkers in the evolution of MTM.Methods: A retrospective study was conducted on patients with MTM as defined by OCT. A minimum follow-up of 6 months was necessary for study inclusion. The effects of comprehensive OCT-based structure on the evolution of MTM, the progression rates, and resolution rates of MTM were evaluated.Results: A total of 120 eyes (120 patients) were included with an average follow-up of 15.4 months. During the follow-up, MTM progressed in 32 eyes (26.67%). The most common pattern of progression observed was the increased extent of retinoschisis in 12 eyes. The multivariate analysis showed that the presence of MTM progression had a significant correlation with internal limiting membrane (ILM) detachment and retinoschisis involved the entire macula at baseline. Five eyes (4.17%) experienced MTM resolution, of which 2 eyes developed disruptions of detached ILM, two eyes developed disruptions of epiretinal membrane, and one eye developed partial posterior vitreous detachment. Eyes with foveal detachment showed the highest progression rate (41.67%) and highest resolution rate (16.67%) compared to the eyes with other foveal complications.Conclusion: ILM detachment is a risk factor for MTM progression and MTM resolution can occur after ILM disruption. These suggest that ILM may play an important role as a biomarker in the evolution of MTM.https://www.frontiersin.org/articles/10.3389/fmed.2021.802626/fullinternal limiting membraneoptical coherence tomographyevolutionbiomarkermyopic traction maculopathy (MTM)
spellingShingle Dong Fang
Jindi Su
Lu Chen
Shaochong Zhang
The Role of Internal Limiting Membrane as a Biomarker in the Evolution of Myopic Traction Maculopathy
Frontiers in Medicine
internal limiting membrane
optical coherence tomography
evolution
biomarker
myopic traction maculopathy (MTM)
title The Role of Internal Limiting Membrane as a Biomarker in the Evolution of Myopic Traction Maculopathy
title_full The Role of Internal Limiting Membrane as a Biomarker in the Evolution of Myopic Traction Maculopathy
title_fullStr The Role of Internal Limiting Membrane as a Biomarker in the Evolution of Myopic Traction Maculopathy
title_full_unstemmed The Role of Internal Limiting Membrane as a Biomarker in the Evolution of Myopic Traction Maculopathy
title_short The Role of Internal Limiting Membrane as a Biomarker in the Evolution of Myopic Traction Maculopathy
title_sort role of internal limiting membrane as a biomarker in the evolution of myopic traction maculopathy
topic internal limiting membrane
optical coherence tomography
evolution
biomarker
myopic traction maculopathy (MTM)
url https://www.frontiersin.org/articles/10.3389/fmed.2021.802626/full
work_keys_str_mv AT dongfang theroleofinternallimitingmembraneasabiomarkerintheevolutionofmyopictractionmaculopathy
AT jindisu theroleofinternallimitingmembraneasabiomarkerintheevolutionofmyopictractionmaculopathy
AT luchen theroleofinternallimitingmembraneasabiomarkerintheevolutionofmyopictractionmaculopathy
AT shaochongzhang theroleofinternallimitingmembraneasabiomarkerintheevolutionofmyopictractionmaculopathy
AT dongfang roleofinternallimitingmembraneasabiomarkerintheevolutionofmyopictractionmaculopathy
AT jindisu roleofinternallimitingmembraneasabiomarkerintheevolutionofmyopictractionmaculopathy
AT luchen roleofinternallimitingmembraneasabiomarkerintheevolutionofmyopictractionmaculopathy
AT shaochongzhang roleofinternallimitingmembraneasabiomarkerintheevolutionofmyopictractionmaculopathy